News and Announcements
Analytica Secures Share Placement of $250,000 to Cornerstone Investor
- Published September 08, 2016 1:49PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
1st September 2016, ASX Announcement
Analytica Ltd (ASX: ALT), manufacturer of the PeriCoach® System, is pleased to announce the allotment of 35,714,285 shares ($250,000) to cornerstone investor INOV8 LLC today. The shares were issued at $0.007. An appendix 3B is attached.
This is the first of two tranches, totalling $500,00 that was announced to the market 27th July 2016. The second tranche is for 35,714,286 shares and settlement is on the 30th September 2016.
These funds, together with anticipated R & D tax incentive for 2016 and the expenditure reduction program, strengthens Analytica’s cash position. Analytica continues to execute its development strategy of:
- Building best in class,
- Gathering evidence to show the product works,
- Proving market acceptance, and
- Negotiating a partnership with a corporation with the resources to commercialise across the world.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
